Abstract The International Index of Erectile Function (IIEF) is a widely used, multi-
dimensional self-report instrument for the evaluation of male sexual function. It is has been …

In less than 20 years, the first selective type 5 phosphodiesterase inhibitor, sildenafil, has
evolved from a potential anti-angina drug to an on-demand oral treatment for erectile …

Introduction Treatment of erectile dysfunction is based on pharmacotherapy for most
patients. Aim To review the current data on pharmacotherapy for erectile dysfunction based …

This article provides a review of the past and current literature on the neurobiology of sexual
function. The influence of endocrine, neurotransmitter, and central nervous system …

Objective To determine the efficacy and safety of sildenafil citrate in the treatment of male
erectile dysfunction. Data Sources The MEDLINE, HealthSTAR, Current Contents, and …

Background: Erectile dysfunction (ED) is a common male sexual disorder. The relative
benefits and harms of pharmacologic therapies for ED, as well as the value of hormonal …

Aim: To review special safety topics associated with sildenafil and to document the
tolerability of 50‐and 100‐mg doses, overall and by age, in men with erectile dysfunction …

Introduction Pharmacotherapy is the usual initial therapy for most men with erectile
dysfunction. Aim To review the current data relating to the efficacy, tolerability and safety of …

Sildenafil is an oral therapy for erectile dysfunction of a broad range of causes. By
selectively inhibiting phosphodiesterase type 5, it allows corpus cavernosum smooth muscle …

This article has been corrected. The original version (PDF) is appended to this article as a
supplement. Background: Erectile dysfunction and low testosterone levels frequently occur …